Data / Form D filings / Goodsprout Co LLC
Goodsprout Co LLC: Form D filings
Goodsprout Co LLC, a pharmaceuticals company in Fort Worth, TX, filed 2 Form D notices with the SEC between 2022 and 2023. The latest, on November 9, 2023, reports $50,000 sold of an offering with no set size to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2733 CULLEN ST., Fort Worth, TX, 76107
- Phone
- (919) 600-9344
- Industry
- Pharmaceuticals
- Entity type
- Limited Liability Company
- Incorporated in
- Texas
- Year incorporated
- 2021
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1905406
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 9, 2023 | New notice | Indefinite | $50,000 | 1 | Oct 31, 2023 | sec.gov | |
| Jan 19, 2022 | New notice | $1,500,000 | $600,000 | $900,000 | 6 | Dec 13, 2021 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Neil S. Foster | Director | |
| Chad S. Saltzman | Executive Officer | |
| Gaylord S. VanGuilder II | Director |
Other pharmaceuticals companies in Texas that filed recently
- LUCIER PHARMACEUTICALS INC offering · Oct 13, 2026
- FibroBiologics, Inc. $1.2 million · Oct 13, 2026
- Eos SENOLYTIX, Inc. $750,000 · Aug 27, 2026
- InnovoTEX Inc. $749,951 · Aug 6, 2026
Every Form D from the week of Nov 6, 2023 · All recent filings in Texas · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Goodsprout Co LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.